Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.29% vs 26.57% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 65.96% vs 338.17% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 49.24% vs 56.88% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 22.40% vs 1.70% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Zeria Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.00% vs 17.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.29% vs 26.57% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -23.45% vs 527.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 65.96% vs 338.17% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -15.07% vs 74.57% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 49.24% vs 56.88% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 12.94% vs 3.98% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 22.40% vs 1.70% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






